IRIDEX (IRIX) Competitors $1.29 +0.22 (+20.56%) Closing price 04:00 PM EasternExtended Trading$1.26 -0.03 (-1.94%) As of 07:17 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock IRIX vs. HYPR, EDAP, ICCM, MLSS, APT, CTCX, INO, DXR, ECOR, and NEPHShould you be buying IRIDEX stock or one of its competitors? The main competitors of IRIDEX include Hyperfine (HYPR), Edap Tms (EDAP), IceCure Medical (ICCM), Milestone Scientific (MLSS), Alpha Pro Tech (APT), Carmell (CTCX), Inovio Pharmaceuticals (INO), Daxor (DXR), electroCore (ECOR), and Nephros (NEPH). These companies are all part of the "medical equipment" industry. IRIDEX vs. Its Competitors Hyperfine Edap Tms IceCure Medical Milestone Scientific Alpha Pro Tech Carmell Inovio Pharmaceuticals Daxor electroCore Nephros IRIDEX (NASDAQ:IRIX) and Hyperfine (NASDAQ:HYPR) are both small-cap medical equipment companies, but which is the better investment? We will contrast the two businesses based on the strength of their risk, analyst recommendations, profitability, media sentiment, valuation, institutional ownership, earnings and dividends. Is IRIX or HYPR more profitable? IRIDEX has a net margin of -14.61% compared to Hyperfine's net margin of -343.42%. Hyperfine's return on equity of -74.19% beat IRIDEX's return on equity.Company Net Margins Return on Equity Return on Assets IRIDEX-14.61% -290.57% -22.86% Hyperfine -343.42%-74.19%-62.40% Which has better earnings and valuation, IRIX or HYPR? IRIDEX has higher revenue and earnings than Hyperfine. IRIDEX is trading at a lower price-to-earnings ratio than Hyperfine, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioIRIDEX$48.67M0.45-$8.91M-$0.43-3.00Hyperfine$11.73M6.83-$40.72M-$0.54-1.91 Which has more volatility and risk, IRIX or HYPR? IRIDEX has a beta of 0.57, indicating that its share price is 43% less volatile than the S&P 500. Comparatively, Hyperfine has a beta of 1.01, indicating that its share price is 1% more volatile than the S&P 500. Do analysts prefer IRIX or HYPR? Hyperfine has a consensus price target of $1.06, suggesting a potential upside of 2.91%. Given Hyperfine's stronger consensus rating and higher possible upside, analysts clearly believe Hyperfine is more favorable than IRIDEX.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score IRIDEX 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Hyperfine 0 Sell rating(s) 1 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.67 Does the media prefer IRIX or HYPR? In the previous week, Hyperfine had 1 more articles in the media than IRIDEX. MarketBeat recorded 1 mentions for Hyperfine and 0 mentions for IRIDEX. Hyperfine's average media sentiment score of 1.89 beat IRIDEX's score of 1.87 indicating that Hyperfine is being referred to more favorably in the news media. Company Overall Sentiment IRIDEX Very Positive Hyperfine Very Positive Do institutionals and insiders hold more shares of IRIX or HYPR? 20.1% of IRIDEX shares are owned by institutional investors. Comparatively, 15.0% of Hyperfine shares are owned by institutional investors. 7.4% of IRIDEX shares are owned by insiders. Comparatively, 31.0% of Hyperfine shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth. SummaryHyperfine beats IRIDEX on 10 of the 16 factors compared between the two stocks. Get IRIDEX News Delivered to You Automatically Sign up to receive the latest news and ratings for IRIX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding IRIX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart IRIX vs. The Competition Export to ExcelMetricIRIDEXLASERS IndustryComputer SectorNASDAQ ExchangeMarket Cap$21.66M$1.00B$28.56B$9.38BDividend YieldN/AN/A3.12%4.06%P/E Ratio-3.00N/A33.4319.86Price / Sales0.4556.591,732.8179.06Price / CashN/A25.0937.5857.53Price / Book9.925.937.675.72Net Income-$8.91M-$60.02M$779.03M$257.80M7 Day Performance25.24%8.01%1.11%1.07%1 Month Performance32.48%12.72%7.42%11.31%1 Year Performance-36.45%1.59%52,958.92%17.01% IRIDEX Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)IRIXIRIDEX1.0777 of 5 stars$1.29+20.6%N/A-49.8%$17.96M$48.80M-3.00120Positive NewsGap UpHigh Trading VolumeHYPRHyperfine1.4457 of 5 stars$0.77-4.4%$1.06+38.6%-33.3%$62.27M$12.89M-1.42190News CoveragePositive NewsGap UpEDAPEdap Tms3.0811 of 5 stars$1.57-1.3%$8.50+441.4%-71.5%$59.45M$69.18M-2.53230Gap DownICCMIceCure Medical2.1591 of 5 stars$1.05-0.5%$2.50+138.1%+35.7%$58.56M$3.27M-3.7560Gap DownMLSSMilestone Scientific3.01 of 5 stars$0.68+1.5%$1.25+83.8%-30.6%$53.36M$8.61M-9.7130Negative NewsAPTAlpha Pro Tech1.1435 of 5 stars$4.78+0.6%N/A-20.1%$51.93M$58.18M12.92120News CoverageCTCXCarmellN/A$2.44+0.8%N/A+275.0%$51.01M$32.84K0.0014Gap UpINOInovio Pharmaceuticals4.0039 of 5 stars$1.33flat$9.75+633.1%-88.0%$48.78M$283.10K-0.42320High Trading VolumeDXRDaxor4.114 of 5 stars$9.86+0.3%$25.00+153.5%+1.2%$47.55MN/A0.0037ECORelectroCore3.4351 of 5 stars$6.09-0.3%$25.50+318.7%+17.5%$45.34M$25.18M-3.9050NEPHNephros2.7773 of 5 stars$4.08+1.2%$5.00+22.5%+56.8%$42.72M$14.16M58.2930News CoverageGap UpHigh Trading Volume Related Companies and Tools Related Companies HYPR Alternatives EDAP Alternatives ICCM Alternatives MLSS Alternatives APT Alternatives CTCX Alternatives INO Alternatives DXR Alternatives ECOR Alternatives NEPH Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:IRIX) was last updated on 7/17/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredTurn $1K into $50K with This DeFi GemI've never been more confident about a DeFi opportunity. This isn't about complex trading or risky bets. Th...Crypto 101 Media | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding IRIDEX Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Share IRIDEX With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
